Does Sildenafil Increase Exercise Performance in Air Pollution?

NCT ID: NCT00808912

Last Updated: 2010-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-12-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine if the ingestion of a standard dose of sildenafil enhances the athletic performance of competitive athletes when exercising in a high pollutant environment verses a low air pollutant environment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will evaluate effects of sildenafil on exercise performance while breathing high levels of emission exhaust ultrafine and fine particulate matter. Exercise performance will be measured by work accumulation (total kJ) during a 6-min maximal effort cycle ergometer ride (CER) done immediately after 30 min cycling at 75% of 6 min mean watts determined from familiarization trial. Peak oxygen consumption, cardiac output, pulmonary artery pressure, diffusion capacity(DLco), and SaO2 will be determined for each trial. Blood and urine will be analyzed for sildenafil using LC/MS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Hypertension Pulmonary Artery Pressure Exercise Performance Air Pollution

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Subjects will exercise in a high air pollutant environment after ingesting a standard dose of sildenafil.

Group Type ACTIVE_COMPARATOR

sildenafil

Intervention Type DRUG

sildenafil 50 mg ingested orally 1 hour prior to exercise testing

2

Subjects will exercise in a low pollutant environment after ingesting a standard dose of sildenafil.

Group Type ACTIVE_COMPARATOR

sildenafil

Intervention Type DRUG

sildenafil 50 mg ingested orally 1 hour prior to exercise testing

3

Subjects will exercise in a high pollutant environment after ingesting a placebo.

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type OTHER

matching placebo for sildenafil 50 mg to be ingested orally 1 hour prior to exercise testing.

4

Subjects will exercise in a low pollutant environment after ingesting a placebo.

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type OTHER

matching placebo for sildenafil 50 mg to be ingested orally 1 hour prior to exercise testing.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sildenafil

sildenafil 50 mg ingested orally 1 hour prior to exercise testing

Intervention Type DRUG

placebo

matching placebo for sildenafil 50 mg to be ingested orally 1 hour prior to exercise testing.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Viagra sugar pill

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non-asthmatic
* asthmatic
* active participants in endurance sports.

Exclusion Criteria

* history of high blood pressure
* history of heart disease
* pulmonary arterial hypertension
* pulmonary emboli
* diagnosis of moderate to severe asthma (FEV1 \<75% predicted)
* pregnant or lactating
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Marywood University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marywood University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kenneth W Rundell, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Marywood University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Marywood University

Scranton, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MU2007-028

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sildenafil Exercise: Role of PDE5 Inhibition
NCT04039087 COMPLETED PHASE2/PHASE3
Use of Sildenafil for Treatment of Urinary Incontinence
NCT02983461 ACTIVE_NOT_RECRUITING PHASE1